Few people with HIV in England starting statins despite new recommendations
Manufacturer’s plans for equitable access to twice-yearly PrEP under fire
CMV antiviral may reduce inflammation and improve immune function in people with HIV
HIV testing requirements must be simplified for injectable PrEP to have a future
Simpler PrEP services – fewer check-ups, online care – work as well as the standard approach
Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms
Coronary artery disease uncommon in people with HIV in Uganda
Why aren’t more people with HIV accessing doxyPEP?
HIV acquisition in women with good adherence to TAF/FTC PrEP is rare
